版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
1、免疫產(chǎn)品簡介picture placeholder第1頁,共16頁。抗體銷量最好的抗體:CKMB、DD、Ferr、Insulin、E2。Roche單抗為凍干品,建議用0.9%的生理鹽水溶解,溶解濃度為10mg/ml。溶解液的儲存條件: 1 周 (+2 to +8C), 12 周 (-25 to -15C). 請避免反復(fù)凍融。第2頁,共16頁??贵w腫瘤:項目抗體批號備注CEAMABTU2 IgG MABM-TU3 IgG 11 353 713 103 10 777 498 103 鼠源單抗凍干AFPMABM-LJ738 IgG MABM-TU11 IgG 11 492 101 103 11 49
2、2 080 103 鼠源單抗凍干FerrMABM-3.170 IgG MABM-4.184 IgG 11 547 089 103 11 547 119 103 鼠源單抗凍干第3頁,共16頁。抗體內(nèi)分泌:項目抗體批號備注LHMABM-11412 IgG MABM-2.406 IgG 11 547 925103 11 547 038103 鼠源單抗凍干FSHMABM-1.303 IgG MABM-W3 IgG 11 493 540103 11 493 531103 鼠源單抗凍干HCGMABM-INN22 IgG MABM-INN2 IgG 11 812 564103 03 116 263103 鼠
3、源單抗凍干PRLMABM-C4E4 IgG MABM-H12G10 IgG 11 458 701103 11 027 689103 鼠源單抗凍干E2PAKK IgG 05 344 255 103兔源多抗液體第4頁,共16頁??贵w甲功:項目抗體批號備注TSH MABM-1.20 IgG MABM-A8 IgG 10 767 7781 03 11 367 978 103 鼠源單抗凍干T3PABS IgG 10 907 332 103 羊源多抗凍干T4PABS IgG 10 767 794 103 羊源多抗凍干第5頁,共16頁??贵w其他:項目抗體批號備注Insulin MABM-ST3 IgG MA
4、BM-BM1 IgG 12 208 750 103 12 208 725 103 鼠源單抗凍干CK-MB MABM-7.4.5 IgG MABM-6.12.47 IgG11 719 815 103 11 719 823 103 鼠源單抗凍干D-DimerMABM-1.2.57 IgG MABM-2.1.16 IgG12 156 903 103 12 045 206 103 鼠源單抗凍干IgEMABM-323 IgG MABM-7H8 IgG 11 543 393 103 11 988 204 103 鼠源單抗凍干CRPPABS IgG 11 888 714 103羊源多抗液體第6頁,共16頁。
5、酶和底物ALP底物項目抗體批號備注ALPAlkaline Phosphatase, EIA Grade10 556 602 103液體酶活3000u/mgALPAlkaline Phosphatase, recombinant, highly active03 137 031 103液體,酶活7000u/mg糖含量20-30%ALPAlkaline Phosphatase, recombinant, highlyactive, carbohydrate reduce03 535 452 103液體,酶活7000u/mg近天然,糖含量5-10%項目抗體批號備注pNPP4-Nitrophenyl
6、Phosphate10 004 847 103結(jié)晶粉末BCIP5-Bromo-4-chloro-3-indolyl-phosphate10 760 978 103結(jié)晶粉末第7頁,共16頁。酶和底物POD底物項目抗體批號備注PODPeroxidase (POD), EIA Grade10 815 462 103凍干酶活225u/mgPODPeroxidase (POD), Grade I10 121 606 103凍干酶活250u/mgPODPeroxidase (POD), Grade II11 378 783 103凍干酶活200u/mgPoly PODPoly POD, EIA Grade
7、11 578 545 103凍干酶活600u/mg項目抗體批號備注TMB3,3,5,5-Tetramethylbenzidine10 203 700 103結(jié)晶粉末第8頁,共16頁。放大系統(tǒng)名稱英文名稱批號備注鏈霉親和素 Streptavidin,recombinant11 520 679 103凍干生物素D-Biotin-N-hydroxysuccinimide ester10 734 250 103白色干粉,短鏈生物素D-Biotinoyl-aminocaproic acid-N-hydroxysuccinimide ester11 003 933 103白色干粉,長鏈鏈霉素包被磁珠Str
8、eptavidin Magnetic Particles11 636 502 103懸濁液磁珠直徑2um左右裸珠第9頁,共16頁。干擾消除蛋白非特異性干擾第10頁,共16頁。非特異性干擾消除蛋白Bovine IgG PABB-IgG (DE)Cat. No. 11293621 Interference reduction in assay system working with polyclonal bovine IgG through blocking of e.g. antibody solid phase interference Basic interference eliminati
9、on. Specials: IgG fraction from bovine plasma, purified by DE chromatography with 5 % aggregated IgGBSA VCat. No. 10738328 Saturation of unoccupied binding sites on the solid phase Basic interference elimination. Specials: Contains no detectable IgGsSheep IgG PABS-IgG (DE)Cat. No. 10717606 Interfere
10、nce reduction in assay system working with polyclonal sheep IgG through blocking of e.g. antibody solid phase interference Basic interference elimination.Rabbit IgG PABK-IgG (DE)Cat. No. 10912280 Interference reduction in assay system working with polyclonal rabbit IgG through blocking of e.g. antib
11、ody solid phase interference Basic interference elimination.第11頁,共16頁。非特異性干擾消除蛋白BPLA I + IVBovine Plasma AlbuminCat. Nos. 1172 6536 1172 6544 0353 5240 Avoidance of non-specific adsorption or antibody interactions for more complex applications with higher demands on sensitivity. Specials: High purit
12、y plus pH 4.5 treatmentType I: purity HPLC 95 %, low content of steroids, lipids and haptens Type IV: purity HPLC 95 %, Type IV NEW !: purity HPLC 95 %, Protease-free ! 2 more production steps compared to old version.Poly BSA I + IICat. Nos.11866737 + 11816438Due to their own polyvalence they show o
13、ptimal protection against polyvalent interference (e.g. in infectious disease assays). The negative charge also avoids hydrophobic interactions.Specials: Very efficient background signal reduction.Type I - acetylated; diameter 30 nmType II succinylated; diameter 40 nm It is recommended to combine a
14、mono- and a polyvalent reagent !The total amount of non specific IEP is recommended to be at 2-5%.第12頁,共16頁。特異性干擾-MAK33 家族單體 IEPsNote: The use of a framework-specific IEP is covered by Roche patent.MAK33 IgG (lyo) Cat. No 1200 941 - monoclonal IgG1 antibody with defined specificity - for test formul
15、ations working with intact IgG1 - mainly for elimination of monomeric and specific interferenceIEP-FrameworkCat. No. 03369846 - for elimination of monomeric and highly specific Interference against the framework regions - caused by highly specific and mostly Mab-therapy-induced HAMAS - developed by
16、comparing the amino acid-sequences of different assay antibodies - use identical immunoreactive amino acid sequences in the framework regions of the interference eliminating reagent as in the test antibodies. - recommended for tumor marker, thyroid and cardiac assays.第13頁,共16頁。特異性干擾-MAK33 家族多聚體IEPs
17、Note: The use of polymerized IEPs is covered by Roche patent.MAK33-IgG1/IgG1 Poly (liquid) Cat. No 1939 661 polymerized version of MAK33 (DSS linker chemistry) for test formulations working with intact IgG1 higher efficiency concerning HAMA interference type 1 (spontaneous HAMAs) mainly for eliminat
18、ion of polymeric and more unspecific interference.MAK33-IgG1/Fab1 Poly (lyo) Cat. No 1368 338 recommended for test systems working with Fab conjugates comparable characteristics as the a.m. MAK33-IgG/IgG1 poly in addition it covers Fab Neo-epitopes mainly for elimination of polymeric and more unspecific interference.Poly MAK IgG2b/Fab2a (lyo) Cat. No 1355 830 recommended for tes
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2022-2023學(xué)年山東省青島市即墨區(qū)高一下學(xué)期期末考試物理試題(解析版)
- 2024年石嘴山客運從業(yè)資格證模擬考試題庫下載
- 《 建設(shè)工程施工合同無效后承包人優(yōu)先受償權(quán)研究》范文
- 2024年通信設(shè)備、計算機及其他電子設(shè)備合作協(xié)議書
- 2024年發(fā)動機試車臺項目發(fā)展計劃
- 2024年氣體檢測監(jiān)控系統(tǒng)項目建議書
- 2024年特異性植物源農(nóng)藥項目發(fā)展計劃
- 2024年電子美容儀項目合作計劃書
- 執(zhí)業(yè)藥師藥事管理與法規(guī)模擬題461
- 西藥執(zhí)業(yè)藥師藥學(xué)專業(yè)知識(一)模擬題324
- 課件第一章信息技術(shù)基礎(chǔ)知識
- 2024湖北機場集團(tuán)限公司公開招聘【193人】高頻考題難、易錯點模擬試題(共500題)附帶答案詳解
- 2024年快遞員職業(yè)技能大賽考試題庫(含答案)
- 汽車維修服務(wù)流程與操作規(guī)范
- 陜西省西安市83中學(xué)2025屆高三第一次聯(lián)考(數(shù)學(xué)試題)試題含解析
- 小數(shù)乘小數(shù)豎式計算練習(xí)100道及答案
- 2024年湖北省公務(wù)員錄用考試《行測》題(網(wǎng)友回憶版)(題目及答案解析)
- Unit 4 Section B 課件人教版2024年七年級英語上冊
- 股權(quán)轉(zhuǎn)讓備忘錄范例
- 南寧廣西南寧市良慶區(qū)自然資源局招聘筆試歷年典型考題及考點附答案解析
-
評論
0/150
提交評論